TB CAB statement on M72/AS01E TB vaccine candidate development

TB CAB Treatment Action Group
April 4, 2019, 3:21 p.m.
post image

Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate

The Global TB Community Advisory Board (TB CAB) submitted a statement to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate convened by the World Health Organization on April 5, 2019.

"Advancing TB research is an urgent scientific, public health, and human rights priority for our communities, and the development of a new TB vaccine is a critical piece of the TB research agenda."

To download the statement, click here.